BETHANIE PATTON: Open Payments
NPI 1992348254 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,565 in 137 payments from 15 companies in 2025. Trend: 2023 $1,305 · 2024 $1,867 · 2025 $2,565
Food & beverage: $2,451Education: $114
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 43 | $878 |
| GlaxoSmithKline, LLC. | 26 | $435 |
| GENZYME CORPORATION | 18 | $311 |
| Insmed, Inc. | 15 | $232 |
| Regeneron Healthcare Solutions, Inc. | 15 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| United Therapeutics Corporation | 4 | $90 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Verona Pharma, Inc. | 2 | $46 |
Products named: DUPIXENT, BREZTRI, TRELEGY ELLIPTA, TEZSPIRE, Arikayce, NUCALA, FASENRA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
